Close Menu

NEW YORK – Roche announced Friday its SARS-CoV-2 quantitative antibody test received CE marking.

The Elecsys Anti-SARS-CoV-2 S test measures the level of antibodies against the region of the viral spike protein that binds to the host cell receptor in patients who have been exposed to the virus. The spike protein has been the focus of multiple vaccines in development, and Roche's test can also be used to characterize a vaccine-induced immune response by measuring the starting level of antibodies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.